CVS Health is splitting in two, according to news reports
CVS Health plans to split into two companies by 2028, according to the Wall Street Journal and Financial Times. One will include retail and mail-order pharmacies, while the other will comprise Aetna, CVS Caremark, and other healthcare businesses. The structure and timeline may change, as the plans are not finalized.
How this was made

The 30-second read
Why it matters
The announced split restructures the company into two focused entities, potentially changing its valuation and influencing the broader health‑care sector.
Market read
The split is a significant corporate action for a large‑cap health‑care company, likely affecting sector dynamics and investor positioning.
What to watch
Regulatory approval risk, execution challenges, and potential tax consequences.
Background
CVS Health is a major U.S. pharmacy chain and health‑insurance provider operating retail pharmacies, mail‑order, Aetna, CVS Caremark, Signify Health and a specialty pharmacy.
Ticker impact
CVS Health announced it will split into two separate companies, separating retail pharmacies from its insurance, PBM and home health businesses.
likely modest pressure as the market prices in the restructuring
Spin‑off creates two distinct entities; investors will reprice each business based on its fundamentals.
Market effects
Healthcare sector may see a clearer split between pharmacy retail and insurance/PBM businesses.
U.S. markets could adjust valuations of other integrated health‑care companies.
Global investors tracking large‑cap health stocks may reassess exposure to CVS and peers.
Counterpoint
The split could dilute synergies and reduce overall enterprise value.
Key entities
- companyCVS Health
U.S. pharmacy and health‑insurance conglomerate.
- business unitAetna
CVS's health‑insurance subsidiary.
- business unitCVS Caremark
Pharmacy benefit manager within CVS.
- business unitSignify Health
Home‑health and specialty pharmacy business.


